Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Company that’s taking Psychedelics from ‘Underground to Mainstream’

(Click image to play video) On a trip to Amsterdam, an item on many traveler’s agendas would be to indulge in some famed Dutch truffles. It is an experience to heighten the mind that Canadian public Company Red Light Holland Corp. (TRIP) ( CSE: T...
Dave Jackson | February 2, 2021 |

Mar 4th 2020, Crypto Chartbook – Sitting on your hands

Sitting on your hands More important than making money is not losing it. If you lose fifty percent of your investment money, you need to make one hundred percent profits, just to break even. This counter intuitive principle works against you. If you trade a normally slow ...
Korbinian Koller | March 5, 2020 |

Can the S&P 500 Bulls Sound the All Clear Now?

The buyers repelled the opening selling pressure, and gradually made their way higher. While it wasn’t smooth sailing throughout the whole session, they overcame every attempt of the sellers. Closing near the daily highs, and with futures little changed during ...
Monica Kingsley | April 9, 2020 |

The Coming Test of the Great S&P 500 Bull Run

S&P 500 has overcome Thursday’s intraday highs, breaking above the 50% Fibonacci retracement of the slide from the mid-Feb highs to the mid-March lows. The setup appears too bullish to ignore. Is it time to jump in on the long side, or is the air getting too th...
Monica Kingsley | April 15, 2020 |

Will the Second Wave Trigger Rally in Gold?

The initial health crisis seems to be under control in many countries. But this is not the end of pandemic and many epidemiologist warn against the second wave of injections. We invite you to read our today’s article about the second wave of the new coronavirus...
Arkadiusz Sieron | June 19, 2020 |

2021: A Breakout Year for Uranium Investments?

(Image via Anfield Energy Inc.) The Athabasca Basin is perhaps best known as the world’s leading source of high-grade uranium and currently supplies about 20% of the world’s uranium. It is a region in the Canadian Shield that enco...
Stockhouse Editorial | February 26, 2021 |

Major and Mid-Tier REE Processors Request High-Grade Samples

Defense Metals Corp. ( TSX-V:DEFN / OTCQB:DFMTF / FSE:35D/ Forum ) announced that it has recently been notified by Welsbach Holdings Pte Ltd. that is has received requests from two interested third-party Rare Earth Element processors for samples of high-grade RE...
Featured Submission | March 23, 2021 |

Profiting from the world's largest cache of commodities

In the quarter century stretching from the late-1880s to the First World War, there was a mad rush by the world's leading powers to occupy and annex African territory. Now, 100 years later, the world's elite again are scrambling to make their respective marks on the continen...
Jason Simpkins | October 28, 2012 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

M2 Velocity Collapses – Could A Bottom In Capital Velocity Be Setting Up?

M2 Velocity is the measurement of capital circulating within the economy. The faster capital circulates within the economy, the more that capital is being deployed within the economy to create output and opportunities for economic growth. When M2 Velocity contracts, capital ...
Chris Vermeulen | May 28, 2020 |
1 2 3